... continued from part 2 ...
===============================================================
Chan DT,
Mok VC,
Poon WS,
Hung KN,
Zhu XL.
PMID: 11406674: Surgical management of PD: a critical review.
Bostantjopoulou S,
Kiosseoglou G,
Katsarou Z,
Alevriadou A.
PMID: 11403342: *Testing Nonverbal Intelligence in PD patients.
Momcilovic B,
Alkhatib HA,
Duerre JA,
Cooley M,
Long WM,
Harris TR,
Lykken GI.
PMID: 11403330: Environmental lead-210 and bismuth-210 in AD and PD.
Chouker M,
Tatsch K,
Linke R,
Pogarell O,
Hahn K,
Schwarz J.
PMID: 11403185: Striatal dopamine transporter binding in PD over 2 years.
Olanow CW,
Watts RL,
Koller WC.
PMID: 11402154: *An algorithm for the management of PD
Tuite PJ.
PMID: 11398632: *PD. An overview of treatments and research.
Dowsey-Limousin P,
Fraix V,
Benabid AL,
Pollak P.
PMID: 11396273: Deep brain stimulation in PD.
Fedele E,
Stefani A,
Bassi A,
Pepicelli O,
Altibrandi MG,
Frasca S,
Giacomini P,
Stanzione P,
Mazzone P.
PMID: 11396272: Effects of apomorphine in PD patients.
Facchinetti F,
Terrazzino S,
D'Arrigo A,
Rinaldi L,
Leon A.
PMID: 11396271: Neurotrophic factors in the therapy of PD.
Bonifati V.
PMID: 11396270: Monogenic Parkinsonisms and the genetics of PD.
Cesaro P,
Peschanski M,
N'Guyen JP.
PMID: 11396267: Treatment of PD by cell transplantation.
McMahon DG.
PMID: 11395359: PD and Parkinsonism in the Elderly.
Barber M,
Stewart D,
Grosset D,
MacPhee G.
PMID: 11395349: *Patient perception of PD management post-surgery.
Adams N.
PMID: 11395149: *Awareness of PD.
Furlanut M,
Furlanut jr M,
Benetello P.
PMID: 11394933: *Monitoring of L-dopa concentrations in PD.
Depatie L,
Lal S.
PMID: 11394190: Apomorphine and dopamine hypothesis of schizophrenia
Louis ED,
Winfield L,
Fahn S,
Ford B.
PMID: 11391759: Speech dysfluency exacerbated by levodopa in PD.
Goetz CG,
Chmura TA,
Lanska DJ.
PMID: 11391755: Seminal figures in the history of Movement Disorders
Tanner CM,
Chamberland J.
PMID: 11391750: Latah in jakarta, indonesia.
Del Dotto P,
Pavese N,
Gambaccini G,
Bernardini S,
Metman LV,
Chase TN,
Bonuccelli U.
PMID: 11391748: Amantadine improves levadopa-induced dyskinesias.
Montastruc JL,
Desboeuf K,
Lapeyre-Mestre M,
Senard JM,
Rascol O,
Brefel-Courbon C.
PMID: 11391747: Comparing bromocriptine and levodopa in de novo PD.
Shulman LM,
Taback RL,
Bean J,
Weiner WJ.
PMID: 11391746: Comorbidity of the nonmotor symptoms of PD.
Tracik F,
Ebersbach G.
PMID: 11391745: Sleep attacks in PD: Polysomnographic recordings.
Hutton JT,
Metman LV,
Chase TN,
Juncos JL,
Koller WC,
Pahwa R,
LeWitt PA,
Samii A,
Tsui JK,
Calne DB,
Waters CH,
Calabrese VP,
Bennett JP,
Barrett R,
Morris JL.
PMID: 11391739: *Transdermal agonist therapy in PD with N-0923 TDS.
Ahlskog JE,
Muenter MD.
PMID: 11391738: *Levodopa-related dyskinesias and motor fluctuations.
Golbe LI,
Lazzarini AM,
Spychala JR,
Johnson WG,
Stenroos ES,
Mark MH,
Sage JI.
PMID: 11391737: The tau A0 allele in PD.
Muriel MP,
Agid Y,
Hirsch E.
PMID: 11391736: Afferent fibers and D1 dopamine receptors in PD.
Datla KP,
Blunt SB,
Dexter DT.
PMID: 11391735: Levodopa not toxic to remaining neurons, may aid
recovery.
Noe Sebastian E,
Irimia Sieira P,
Pomares Arias EM,
Martinez Vila E,
Luquin Piudo MR.
PMID: 11391498: *Neuropsychiatric disorders in PD.
Montastruc JL,
Brefel-Courbon C,
Senard JM,
Bagheri H,
Ferreira J,
Rascol O,
Lapeyre-Mestre M.
PMID: 11391132: Sleep attacks and antiparkinsonian drugs.
Jansen PA,
Herings RM,
Samson MM,
De Vreede PL,
Schuurmans-Daemen LM,
Hovestadt A,
Verhaar HJ,
Van Laar T.
PMID: 11391131: Quick Titration of Pergolide with Domperidone Safe.
Gschwandtner U,
Aston J,
Renaud S,
Fuhr P.
PMID: 11391129: Pathologic gambling and PD.
Metman LV,
Gillespie M,
Farmer C,
Bibbiani F,
Konitsiotis S,
Morris M,
Shill H,
Bara-Jimenez W,
Mouradian MM,
Chase TN.
PMID: 11391128: *Transdermal dopaminergic stimulation in advanced PD.
Heikkinen H,
Nutt JG,
LeWitt PA,
Koller WC,
Gordin A.
PMID: 11391126: Entacapone and L-Dopa in PD.
Clarke CE,
Cooper JA,
Holdich TA.
PMID: 11391123: Remacemide in PD with response fluctuations.
Momcilovic B,
Alkhatib HA,
Duerre JA,
Cooley M,
Long WM,
Harris TR,
Lykken GI.
PMID: 11391093: Environmental lead-210 and bismuth-210 accrue in AD
and PD.
Jung Y,
Surh Y.
PMID: 11390186: Oxidative damage induced by salsolinol.
Arciniegas DB,
Topkoff JL,
Held K,
Frey L.
PMID: 11389805: *Psychosis Due to Neurologic Conditions.
Johnson S.
PMID: 11388783: Micronutrients in schizophrenia, epilepsy, autism and PD.
Lindvall O,
Hagell P.
PMID: 11388662: Cell therapy and transplantation in PD.
Goedert M.
PMID: 11388653: PD and other alpha-synucleinopathies.
Sugita M,
Izuno T,
Tatemichi M,
Otahara Y.
PMID: 11388498: The relationship between smoking and PD.
Zakharov VV,
Akhutina TV,
Yakhno NN.
PMID: 11388367: Memory impairment in PD.
Rosenfeld JV.
PMID: 11386815: DBS superior to ablative surgery: moderator's view.
Thompson PD.
PMID: 11386814: DBS superior to ablative surgery: the case against.
Peters S,
Eising EG,
Przuntek H,
Muller T.
PMID: 11386806: Vascular Parkinsonism.
Tjaden K.
PMID: 11386485: Perception of articulatory rate in PD.
Hobson JP,
Edwards NI,
Meara RJ.
PMID: 11386393: *New, simpler PD Activities of Daily Living Scale.
Kirkey KL,
Johnson CC,
Rybicki BA,
Peterson EL,
Kortsha GX,
Gorell JM.
PMID: 11385640: Occupations at risk for PD.
Le Couteur DG,
Davis MW,
Webb M,
Board PG.
PMID: 11385274: Multidrug-resistance-associated protein and PD.
Wang YC,
Liu HC,
Liu TY,
Hong CJ,
Tsai SJ.
PMID: 11385264: Alpha-1-antichymotrypsin polymorphism in PD.
Clarke CE.
PMID: 11385027: *PD and movement disorders. diagnosis and treatment.
Schimpff RM,
Avard C,
Fenelon G,
Lhiaubet AM,
Tenneze L,
Vidailhet M,
Rostene W.
PMID: 11385014: Increased plasma neurotensin concentrations in PD.
McShane RH,
Nagy Z,
Esiri MM,
King E,
Joachim C,
Sullivan N,
Smith AD.
PMID: 11385006: Anosmia in dementia associated with Lewy bodies not AD.
Holroyd S,
Currie L,
Wooten GF.
PMID: 11385005: *Hallucinations and delusions in PD.
Barnes J,
David AS.
PMID: 11385004: *Visual hallucinations in PD.
Mindham RH.
PMID: 11385000: *Visual hallucinations in PD.
Glass M.
PMID: 11383976: *The role of cannabinoids in neurodegenerative diseases.
Herishanu YO,
Medvedovski M,
Goldsmith JR,
Kordysh E.
PMID: 11383940: *A study of PD in urban population of southern Israel.
Wetter TC,
Trenkwalder C,
Gershanik O,
Hogl B.
PMID: 11383385: Polysomnographic measures in PD.
Teo C,
Rasco L,
Skinner RD,
Garcia-Rill E.
PMID: 11382858: Sleep state-dependent p1 potential in PD
post-pallidotomy.
Tan AK.
PMID: 11379409: *Current and emerging treatments in PD.
(ps: those studies above marked * hold special interest for
me and i will be posting the individual abstracts separately)
===============================================================
janet paterson: an akinetic rigid subtype, albeit perky, parky .
pd: 54/41/37 cd: 54/44/43 tel: 613 256 8340 email: [log in to unmask] .
snail mail: 375 Country Street, Apt 301, Almonte, Ontario, Canada, K0A 1A0 .
a new voice: the nnnewsletter: http://groups.yahoo.com/group/janet313/ .
a new voice: the wwweb site: http://www.geocities.com/janet313/ .
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
